Jennifer B Green

Jennifer B Green

UNVERIFIED PROFILE

Are you Jennifer B Green?   Register this Author

Register author
Jennifer B Green

Jennifer B Green

Publications by authors named "Jennifer B Green"

Are you Jennifer B Green?   Register this Author

60Publications

1367Reads

37Profile Views

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.

Int J Cardiol 2019 08 30;289:58-62. Epub 2019 Apr 30.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.04.085DOI Listing
August 2019

Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.

J Am Coll Cardiol 2019 Aug;74(8):1107-1115

Duke Center for Atrial Fibrillation, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.07.020DOI Listing
August 2019

Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163.

Diabetes Care 2019 06;42(6):e95

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-2597DOI Listing
June 2019

Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".

Am J Manag Care 2019 04;25(4):171-172

AstraZeneca, 1800 Concord Pike, Wilmington, DE 19803. Email:

View Article

Download full-text PDF

Source
April 2019

Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.

J Am Coll Cardiol 2019 02;73(5):602-611

Department of Medicine, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.11.033DOI Listing
February 2019

Progression of glucose-lowering diabetes therapy in TECOS.

Endocrinol Diabetes Metab 2019 Jan 22;2(1):e00053. Epub 2018 Dec 22.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford Oxford UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/edm2.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354756PMC
January 2019

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.

Diabetes Obes Metab 2018 10 19;20(10):2379-2388. Epub 2018 Jun 19.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13377DOI Listing
October 2018

Preventing Heart Failure in Diabetes: Glycemic Targets or Class Effect?

JACC Heart Fail 2018 10 5;6(10):831-832. Epub 2018 Sep 5.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.07.014DOI Listing
October 2018

The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.

Clin Cardiol 2018 Sep 21;41(9):1259-1267. Epub 2018 Sep 21.

Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.23054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490104PMC
September 2018

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.

Hypertension 2017 11 28;70(5):907-914. Epub 2017 Aug 28.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., D.S.G., Y.L., J.B.G., E.D.P.); Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill (J.B.B.); Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ (S.S.E.); The George Washington University Biostatistics Center, Rockville, MD (J.M.L.); Munich Diabetes Research Institute, Helmholtz Center, Germany (E.S.); Department of Cardiovascular Sciences, University of Leuven, Belgium (F.V.d.W.); and Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Churchill Hospital, United Kingdom (R.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638706PMC
November 2017

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Circulation 2017 Sep 16;136(13):1193-1203. Epub 2017 Jun 16.

From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (N.J.P., A.M.N., K.S.P., J.B.G., Y.L., E.D.P.); Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom (M.A.B., R.R.H.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); St. Michael's Hospital, University of Toronto, Ontario, Canada (R.G.J.); Division of Cardiology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Noordwest Ziekenhuisgroep, Department of Cardiology, Alkmaar, the Netherlands (J.C.H.); Department of Cardiology, Oslo University Hospital, and University of Oslo, Norway (S.H.); University of Helsinki and Helsinki University Hospital, Finland (T.E.S.); University of Oulu, Center for Life Course Health Research, Finland (T.E.S.); and Department of Endocrinology and Metabolism, School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey (T.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614823PMC
September 2017

Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions.

Curr Diab Rep 2017 Sep;17(9):67

Department of Medicine, Division of Endocrinology, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-017-0898-8DOI Listing
September 2017

Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?

PLoS One 2016 18;11(5):e0156068. Epub 2016 May 18.

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156068PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871563PMC
July 2017

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Diabetes Care 2017 Apr 5;40(4):494-501. Epub 2017 Jan 5.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-1135DOI Listing
April 2017

Pancreatic Safety of Sitagliptin in the TECOS Study.

Diabetes Care 2017 Feb 14;40(2):164-170. Epub 2016 Sep 14.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-2780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864139PMC
February 2017

Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.

Clin Cardiol 2017 Jan 26;40(1):38-45. Epub 2016 Oct 26.

Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490426PMC
January 2017

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2015 Jul 8;373(3):232-42. Epub 2015 Jun 8.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham (J.B.G., J.G., M.J.P., E.D.P.) and University of North Carolina School of Medicine, Chapel Hill (J.B.B.) - both in North Carolina; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom (M.A.B., R.R.H.); Canadian VIGOUR Centre, University of Alberta, Edmonton, AB (P.W.A.) and St. Michael's Hospital, University of Toronto, Toronto (R.J.) - both in Canada; Merck, Kenilworth, NJ (S.S.E., K.D.K., J.K., S.K., P.P.S., S.S.); George Washington University Biostatistics Center, Rockville, MD (J.M.L.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Munich Diabetes Research Group, Helmholtz Center, Neuherberg, Germany (E.S.); and University of Leuven, Leuven, Belgium (F.V.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501352DOI Listing
July 2015

Update in endocrinology: evidence published in 2014.

Authors:
Jennifer B Green

Ann Intern Med 2015 May;162(9):W91-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M15-0153DOI Listing
May 2015

Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial.

J Diabetes Complications 2013 Nov-Dec;27(6):633-6. Epub 2013 Sep 19.

Duke Clinical Research Institute, Duke University Health Care System, Durham, NC, USA; Department of Medicine, Duke University Health Care System, Durham, NC, USA; Claude D. Pepper OAIC, Duke University Health Care System, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2013.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874717PMC
July 2014

Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox.

Authors:
Jennifer B Green

Postgrad Med 2014 May;126(3):190-204

Associate Professor of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2014.05.2767DOI Listing
May 2014

Forearm instability.

J Hand Surg Am 2014 Jan 6;39(1):156-67. Epub 2013 Dec 6.

Philadelphia Hand Center, King of Prussia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhsa.2013.07.010DOI Listing
January 2014

Diabetes trials: is an ounce of prevention enough?

Authors:
Jennifer B Green

Expert Rev Endocrinol Metab 2013 Sep;8(5):419-421

a Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, DUMC Box 3850, 2400 Pratt Street, North Pavilion, Durham, NC 27705, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17446651.2013.827382DOI Listing
September 2013

Glycemic management in diabetes and the associated cardiovascular risk: are we helping or hurting our patients?

Circ J 2012 16;76(7):1572-80. Epub 2012 Jun 16.

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1253/circj.cj-12-0428DOI Listing
October 2012

Is silent myocardial infarction more common in women with type 2 diabetes than in men?

J Diabetes Complications 2012 Mar-Apr;26(2):118-22. Epub 2012 Mar 24.

Department of Medicine, Division of Endocrinology and Diabetes, University of Minnesota, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2012.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348405PMC
September 2012

The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.

Authors:
Jennifer B Green

Postgrad Med 2012 Jul;124(4):54-61

Division of Endocrinology, Duke University Medical Center, Durham, NC 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2012.07.2566DOI Listing
July 2012

Bilateral distal biceps tendon ruptures.

J Hand Surg Am 2012 Jan 25;37(1):120-3. Epub 2011 Nov 25.

Department of Orthopaedic Surgery, Newton Wellesley Hospital, Newton, MA 02462, USA.

View Article

Download full-text PDF

Source
http://www.jmedicalcasereports.com/content/pdf/1752-1947-7-2
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S036350231101279
Publisher Site
http://dx.doi.org/10.1016/j.jhsa.2011.09.043DOI Listing
January 2012

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy.

Drug Healthc Patient Saf 2010 28;2:7-19. Epub 2010 Jan 28.

Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition. Duke University Medical Center, Durham, NC, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108711PMC
http://dx.doi.org/10.2147/dhps.s6270DOI Listing
July 2011

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience.

Diabetes Technol Ther 2011 Jun 13;13(6):601-6. Epub 2011 Apr 13.

Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/dia.2010.0225
Publisher Site
http://dx.doi.org/10.1089/dia.2010.0225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101919PMC
June 2011

First reported case of unilateral Graves' disease in the left lobe of a bilobar thyroid gland.

Thyroid 2011 Jun 12;21(6):683-6. Epub 2011 May 12.

Division of Endocrinology, Duke University Department of Medicine, Durham, North Carolina 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2010.0343DOI Listing
June 2011

Clinical utility of fixed combinations of sitagliptin-metformin in treatment of type 2 diabetes.

Diabetes Metab Syndr Obes 2010 Oct 27;3:363-72. Epub 2010 Oct 27.

Department of Medicine, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DMSOTT.S10195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047989PMC
October 2010

Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes.

Clin Med Ther 2009 Aug;1:1103-1119

Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition. Duke University Medical Center, Durham, North Carolina, United States of America (USA).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335272PMC
http://dx.doi.org/10.4137/cmt.s2109DOI Listing
August 2009

Forearm instability.

J Hand Surg Am 2009 May-Jun;34(5):953-61

The Philadelphia Hand Center, Jefferson University, Philadelphia, PA 19406, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhsa.2009.03.018DOI Listing
July 2009

Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

Curr Diab Rep 2007 Oct;7(5):369-75

Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Baker House Room 280, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-007-0060-0DOI Listing
October 2007

Are sulfonylureas passé?

Curr Diab Rep 2006 Nov;6(5):373-7

Duke University Medical Center, Division of Endocrinology, DUMC Box 3222, Baker House, Room 280, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-006-0008-9DOI Listing
November 2006

Exercising decisions. Choosing and using equipment in rehab involves thought and careful planning.

Authors:
Jennifer B Green

Rehab Manag 2004 Dec;17(10):30-1

View Article

Download full-text PDF

Source
December 2004

Conquering the complex.

Rehab Manag 2004 Aug-Sep;17(7):22, 24-5

Spaulding Rehabilitation Hospital, Framingham, Mass, USA.

View Article

Download full-text PDF

Source
October 2004